The new statins? Millions of us already take pills that reduce cholesterol and cut our heart attack risk. Now experts say we should be on a drug to target another potential killer in the blood
Related Articles
-
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
For the first time, some Medicare beneficiaries will be able to access Novo Nordisk's Wegovy without having to shoulder the total monthly price tag.
-
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugs
Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery. On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors […] © 2024 TechCrunch. All rights reserved. For personal use only.
-
Right amount of coffee reduces heart palpitations by 13%
Having the right number of cups of coffee can reduce your risk of heart attack and stroke